Trial Profile
Efficacy of Sacubitril-Valsartan in heart failure patients with and without an implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2017
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 28 Sep 2017 New trial record
- 30 Aug 2017 Results assessing efficacy Sacubitril-Valsartan in heart failure patients with and without an implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT), were presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.